Adams Kendra bought CCCC
March 7, 2024 · Form 4 insider transaction
Adams Kendra bought 45,000 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderAdams Kendra
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 7, 2024
Filing dateMarch 8, 2024
Shares owned after45,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.; This option vests and becomes exercisable in sixteen equal quarterly installments, with the first installment vested on May 14, 2022, subject to the Reporting Person's continued service on each vesting date.